At the molecular level, after long-term AngII treatment, the ratio of phospho-ERK to ERK, which is a known marker activated in cardiac hypertrophy, was highly increased in ATIP1-KO hearts, confirming the lack of the inhibitory effect of ATIP1 on ERK activity in our mice [20]. Here, AGT is linked to cardiac hypertrophy.